212 related articles for article (PubMed ID: 26502638)
1. Pluronic F-127 Stabilised Docetaxel Nanocrystals Improve Apoptosis by Mitochondrial Depolarization in Breast Cancer Cells: Pharmacokinetics and Toxicity Assessment.
Pawar VK; Gupta S; Singh Y; Meher JG; Sharma K; Singh P; Gupta A; Bora HK; Chaurasia M; Chourasia MK
J Biomed Nanotechnol; 2015 Oct; 11(10):1747-63. PubMed ID: 26502638
[TBL] [Abstract][Full Text] [Related]
2. Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer To Overcome the Limitations of Systemic Chemotherapy.
Bathara M; Date T; Chaudhari D; Ghadi R; Kuche K; Jain S
Mol Pharm; 2020 Jul; 17(7):2473-2486. PubMed ID: 32496783
[TBL] [Abstract][Full Text] [Related]
3. Perspectives of nanoemulsion assisted oral delivery of docetaxel for improved chemotherapy of cancer.
Verma P; Meher JG; Asthana S; Pawar VK; Chaurasia M; Chourasia MK
Drug Deliv; 2016; 23(2):479-88. PubMed ID: 24901205
[TBL] [Abstract][Full Text] [Related]
4. Development of docetaxel nanocapsules for improving in vitro cytotoxicity and cellular uptake in MCF-7 cells.
Singh SK; Banala VT; Gupta GK; Verma A; Shukla R; Pawar VK; Tripathi P; Mishra PR
Drug Dev Ind Pharm; 2015; 41(11):1759-68. PubMed ID: 25686725
[TBL] [Abstract][Full Text] [Related]
5. Pluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluation.
Chen L; Sha X; Jiang X; Chen Y; Ren Q; Fang X
Int J Nanomedicine; 2013; 8():73-84. PubMed ID: 23319859
[TBL] [Abstract][Full Text] [Related]
6. Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats.
Pawar H; Surapaneni SK; Tikoo K; Singh C; Burman R; Gill MS; Suresh S
Drug Deliv; 2016 May; 23(4):1453-68. PubMed ID: 26878325
[TBL] [Abstract][Full Text] [Related]
7. Development of docetaxel nanocrystals surface modified with transferrin for tumor targeting.
Choi JS; Park JS
Drug Des Devel Ther; 2017; 11():17-26. PubMed ID: 28031702
[TBL] [Abstract][Full Text] [Related]
8. Surface modification of docetaxel nanocrystals with HER2 antibody to enhance cell growth inhibition in breast cancer cells.
Choi JS; Park JS
Colloids Surf B Biointerfaces; 2017 Nov; 159():139-150. PubMed ID: 28783505
[TBL] [Abstract][Full Text] [Related]
9. Docetaxel distribution following intraperitoneal administration in mice.
Zahedi P; De Souza R; Piquette-Miller M; Allen C
J Pharm Pharm Sci; 2011; 14(1):90-9. PubMed ID: 21501556
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex
Ghassami E; Varshosaz J; Jahanian-Najafabadi A; Minaiyan M; Rajabi P; Hayati E
Int J Nanomedicine; 2018; 13():493-504. PubMed ID: 29416331
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of co-formulated docetaxel and curcumin biodegradable nanoparticles for parenteral administration.
Pawar H; Wankhade SR; Yadav DK; Suresh S
Pharm Dev Technol; 2016 Sep; 21(6):725-36. PubMed ID: 26330159
[TBL] [Abstract][Full Text] [Related]
12. Co-delivery of docetaxel and Poloxamer 235 by PLGA-TPGS nanoparticles for breast cancer treatment.
Tang X; Liang Y; Feng X; Zhang R; Jin X; Sun L
Mater Sci Eng C Mater Biol Appl; 2015 Apr; 49():348-355. PubMed ID: 25686959
[TBL] [Abstract][Full Text] [Related]
13. Improved antitumor efficacy and reduced toxicity of docetaxel using anacardic acid functionalized stealth liposomes.
Kushwah V; Jain DK; Agrawal AK; Jain S
Colloids Surf B Biointerfaces; 2018 Dec; 172():213-223. PubMed ID: 30172202
[TBL] [Abstract][Full Text] [Related]
14. Sustained release docetaxel-incorporated lipid nanoparticles with improved pharmacokinetics for oral and parenteral administration.
Qureshi OS; Kim HS; Zeb A; Choi JS; Kim HS; Kwon JE; Kim MS; Kang JH; Ryou C; Park JS; Kim JK
J Microencapsul; 2017 May; 34(3):250-261. PubMed ID: 28557649
[TBL] [Abstract][Full Text] [Related]
15. Adenosine conjugated lipidic nanoparticles for enhanced tumor targeting.
Swami R; Singh I; Jeengar MK; Naidu VG; Khan W; Sistla R
Int J Pharm; 2015; 486(1-2):287-96. PubMed ID: 25839415
[TBL] [Abstract][Full Text] [Related]
16. A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel.
Yang Y; Wang J; Zhang X; Lu W; Zhang Q
J Control Release; 2009 Apr; 135(2):175-82. PubMed ID: 19331864
[TBL] [Abstract][Full Text] [Related]
17. Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity.
Wang L; Liu Z; Liu D; Liu C; Juan Z; Zhang N
Int J Pharm; 2011 Jul; 413(1-2):194-201. PubMed ID: 21540085
[TBL] [Abstract][Full Text] [Related]
18. Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells.
da Rocha MCO; da Silva PB; Radicchi MA; Andrade BYG; de Oliveira JV; Venus T; Merker C; Estrela-Lopis I; Longo JPF; Báo SN
J Nanobiotechnology; 2020 Mar; 18(1):43. PubMed ID: 32164731
[TBL] [Abstract][Full Text] [Related]
19. Blood-brain barrier-penetrating amphiphilic polymer nanoparticles deliver docetaxel for the treatment of brain metastases of triple negative breast cancer.
He C; Cai P; Li J; Zhang T; Lin L; Abbasi AZ; Henderson JT; Rauth AM; Wu XY
J Control Release; 2017 Jan; 246():98-109. PubMed ID: 28017889
[TBL] [Abstract][Full Text] [Related]
20. PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy.
Wang Y; Chen L; Tan L; Zhao Q; Luo F; Wei Y; Qian Z
Biomaterials; 2014 Aug; 35(25):6972-85. PubMed ID: 24836952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
